Tuesday, April 15, 2014 2:12:38 PM
I sense that the buyer(s) from a week ago have not gone away. Playing possum. They may be back.
Hoping so.
I anticipate a lot more volatility ahead. Some stocks probably have bottomed for this market pull back.
The markets worst fears will probably not be realized. I doubt Putin will send forces across the border. He is winning big time just by applying pressure. He is looking good in many circles, but things will get ugly if uniformed Russians spill blood. The earnings season will probably be satisfactory, and economic numbers decent.
Still anticipating a real correction down the road.
Don't like current Fed policies. Banking Fed and U.S. federal. Stand off in Nevada just one more symptom of big govt. overreach, and economic retardation. Pictures and video speak louder than words. Sooner or later the Feds will look like the "Emperors With No Clothes".
I keep reading headlines with all these scary viral outbreaks going on. Some countries are all ready in panic mode. The WHO (World Health Organization) is sounding alarms. Time is perfect for NNVC's technology. I can't be alone in assessing this.
NNVC's time to shine may be coming sooner than we all expect.
Hoping so.
Best wishes to all.
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM